Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01928225
Recruitment Status : Enrolling by invitation
First Posted : August 23, 2013
Last Update Posted : May 13, 2016
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Cynthia S Firnhaber, University of Witwatersrand, South Africa

No Study Results Posted on for this Study
  Recruitment Status : Enrolling by invitation
  Estimated Primary Completion Date : December 2016
  Estimated Study Completion Date : March 2017